Your browser doesn't support javascript.
loading
Down syndrome cell adhesion molecule like-1 (DSCAML1) links the GABA system and seizure susceptibility.
Hayase, Yoneko; Amano, Shigeru; Hashizume, Koichi; Tominaga, Takashi; Miyamoto, Hiroyuki; Kanno, Yukie; Ueno-Inoue, Yukiko; Inoue, Takayoshi; Yamada, Mayumi; Ogata, Shigehiro; Balan, Shabeesh; Hayashi, Ken; Miura, Yoshiki; Tokudome, Kentaro; Ohno, Yukihiro; Nishijo, Takuma; Momiyama, Toshihiko; Yanagawa, Yuchio; Takizawa, Akiko; Mashimo, Tomoji; Serikawa, Tadao; Sekine, Akihiro; Nakagawa, Eiji; Takeshita, Eri; Yoshikawa, Takeo; Waga, Chikako; Inoue, Ken; Goto, Yu-Ichi; Nabeshima, Yoichi; Ihara, Nobuo; Yamakawa, Kazuhiro; Taya, Shinichiro; Hoshino, Mikio.
  • Hayase Y; Department of Biochemistry and Cellular Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), 4-1-1 Ogawa-higashi, Kodaira, Tokyo, 187-8502, Japan. yhayase887@yahoo.co.jp.
  • Amano S; Graduate School of Medicine Faculty of Health Science, Department of Laboratory Medicine, Kyoto University, Kyoto, 606-8501, Japan.
  • Hashizume K; Department of Biochemistry and Cellular Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), 4-1-1 Ogawa-higashi, Kodaira, Tokyo, 187-8502, Japan.
  • Tominaga T; Laboratory for Neural Circuit System, Institute of Neuroscience, Tokushima Bunri University, Sanuki, 769-2300, Japan.
  • Miyamoto H; International Research Center for Neurointelligence (IRCN), The University of Tokyo, Tokyo, 187-8502, Japan.
  • Kanno Y; Department of Biochemistry and Cellular Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), 4-1-1 Ogawa-higashi, Kodaira, Tokyo, 187-8502, Japan.
  • Ueno-Inoue Y; Department of Biochemistry and Cellular Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), 4-1-1 Ogawa-higashi, Kodaira, Tokyo, 187-8502, Japan.
  • Inoue T; Department of Biochemistry and Cellular Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), 4-1-1 Ogawa-higashi, Kodaira, Tokyo, 187-8502, Japan.
  • Yamada M; Research Center for Dynamic Living Systems, Graduate School of Biostudies, Kyoto University, Kyoto, 606-8501, Japan.
  • Ogata S; Department of Biochemistry and Cellular Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), 4-1-1 Ogawa-higashi, Kodaira, Tokyo, 187-8502, Japan.
  • Balan S; Laboratory for Molecular Psychiatry, RIKEN Center for Brain Science, 2-1 Hirosawa, Wako, Saitama, 351-0198, Japan.
  • Hayashi K; Department of Biochemistry and Cellular Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), 4-1-1 Ogawa-higashi, Kodaira, Tokyo, 187-8502, Japan.
  • Miura Y; Department of Biochemistry and Cellular Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), 4-1-1 Ogawa-higashi, Kodaira, Tokyo, 187-8502, Japan.
  • Tokudome K; Department of Pharmacology, Osaka University of Pharmaceutical Sciences, Takatsuki, Osaka, 569-1094, Japan.
  • Ohno Y; Department of Pharmacology, Osaka University of Pharmaceutical Sciences, Takatsuki, Osaka, 569-1094, Japan.
  • Nishijo T; Department of Pharmacology, Jikei University School of Medicine, Tokyo, 105-8461, Japan.
  • Momiyama T; Department of Pharmacology, Jikei University School of Medicine, Tokyo, 105-8461, Japan.
  • Yanagawa Y; Genetic and Behavioral Neuroscience, Gunma University Graduate School of Medicine, Maebashi, Gunma, 371-8511, Japan.
  • Takizawa A; Institute of Laboratory Animals, Graduate School of Medicine, Kyoto University, Kyoto, 606-8501, Japan.
  • Mashimo T; Institute of Laboratory Animals, Graduate School of Medicine, Kyoto University, Kyoto, 606-8501, Japan.
  • Serikawa T; Laboratory Animal Research Center, Institute of Medical Science, The University of Tokyo, Tokyo, 108-839, Japan.
  • Sekine A; Institute of Laboratory Animals, Graduate School of Medicine, Kyoto University, Kyoto, 606-8501, Japan.
  • Nakagawa E; Omics-Based Medicine, Center for Preventive Medical Science, Chiba University, Chiba, 260-0856, Japan.
  • Takeshita E; Department of Pediatric Neurology, National Center Hospital, NCNP, Tokyo, 187-8551, Japan.
  • Yoshikawa T; Department of Pediatric Neurology, National Center Hospital, NCNP, Tokyo, 187-8551, Japan.
  • Waga C; Laboratory for Molecular Psychiatry, RIKEN Center for Brain Science, 2-1 Hirosawa, Wako, Saitama, 351-0198, Japan.
  • Inoue K; Department of Mental Retardation and Birth Defect Research, NCNP, Tokyo, 187-8551, Japan.
  • Goto YI; Department of Mental Retardation and Birth Defect Research, NCNP, Tokyo, 187-8551, Japan.
  • Nabeshima Y; Department of Mental Retardation and Birth Defect Research, NCNP, Tokyo, 187-8551, Japan.
  • Ihara N; Foundation for Biomedical Research and Innovation, Kobe, 650-0047, Japan.
  • Yamakawa K; Department of Biochemistry and Cellular Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), 4-1-1 Ogawa-higashi, Kodaira, Tokyo, 187-8502, Japan.
  • Taya S; Graduate School of Medical Science, Nagoya City University, Nagoya, 467-8601, Japan.
  • Hoshino M; Department of Biochemistry and Cellular Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), 4-1-1 Ogawa-higashi, Kodaira, Tokyo, 187-8502, Japan. s-taya@ncnp.go.jp.
Acta Neuropathol Commun ; 8(1): 206, 2020 11 30.
Article en En | MEDLINE | ID: mdl-33256836
ABSTRACT
The Ihara epileptic rat (IER) is a mutant model with limbic-like seizures whose pathology and causative gene remain elusive. In this report, via linkage analysis, we identified Down syndrome cell adhesion molecule-like 1(Dscaml1) as the responsible gene for IER. A single base mutation in Dscaml1 causes abnormal splicing, leading to lack of DSCAML1. IERs have enhanced seizure susceptibility and accelerated kindling establishment. Furthermore, GABAergic neurons are severely reduced in the entorhinal cortex (ECx) of these animals. Voltage-sensitive dye imaging that directly presents the excitation status of brain slices revealed abnormally persistent excitability in IER ECx. This suggests that reduced GABAergic neurons may cause weak sustained entorhinal cortex activations, leading to natural kindling via the perforant path that could cause dentate gyrus hypertrophy and epileptogenesis. Furthermore, we identified a single nucleotide substitution in a human epilepsy that would result in one amino acid change in DSCAML1 (A2105T mutation). The mutant DSCAML1A2105T protein is not presented on the cell surface, losing its homophilic cell adhesion ability. We generated knock-in mice (Dscaml1A2105T) carrying the corresponding mutation and observed reduced GABAergic neurons in the ECx as well as spike-and-wave electrocorticogram. We conclude that DSCAML1 is required for GABAergic neuron placement in the ECx and suppression of seizure susceptibility in rodents. Our findings suggest that mutations in DSCAML1 may affect seizure susceptibility in humans.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Convulsiones / Moléculas de Adhesión Celular / Corteza Entorrinal / Neuronas GABAérgicas Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Convulsiones / Moléculas de Adhesión Celular / Corteza Entorrinal / Neuronas GABAérgicas Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Año: 2020 Tipo del documento: Article